Contact Supplier

Contact Supplier

To get in touch with VTU Technology bring out licensing opportunities to BIO-International 2016, simply fill out the form below.

Subscribe to Supplier

Subscribe to Supplier


VTU Technology bring out licensing opportunities to BIO-International 2016

news-releasesVALIDOGEN GmbH
June 1st 2016

Grambach, Austria: – Protein expression specialist VTU Technology will be returning to San Francisco with the huge BIO-International Convention early next week.

VTU will use this year’s appearance to showcase its latest advances in exploiting its world-leading Pichia pastoris recombinant expression platform for higher efficiency production of a wide range of biological protein candidates.

VTU will be a prominent presence in the Austrian Pavilion (Booth 2417) at BIO-International, which the company has attended regularly since 2008.

Licensing opportunities

Additionally VTU will feature new enhancements to its recently developed glycoprotein production package – a combination of proprietary Pichia pastoris expression with RCT´s Pichia GlycoSwitch system that enables boosted production of tailored glycoproteins.

VTU will also use the Convention’s advanced networking facilities to seek new partners and collaborators, offering out-licensing and co-development opportunities for several recombinant proteins as well as ultra-competitive protein production processes.

Dr. Thomas Purkarthofer, Head of Business Development, and Dr. Roland Weis, Head of Operations will lead VTU’s team at BIO-International. Both will be available for meetings and one-to-one conferences using the event’s sophisticated web-based networking system.

Astonishing protein yields

“Our experience over the previous years just confirmed for us the importance of having effective face-to face meetings with partners and customers,” said Dr. Purkarthofer.

“With the advances we’ve made during the past year, we can show and even broader and more powerful Pichia pastoris protein production platform, with astonishing protein yields achieved over the past 12 months,” he added.

“These results just confirm the power of the underlying technology,” said Dr. Purkarthofer.

About VTU Technology

VTU Technology, a leading contract research and development company, offers the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant protein expression / production enabling highest productivities delivering up to 25 g/L of secreted protein (record productivities of 35 g/L) within a few weeks development time.

VTU´s yield-enhancing Pichia pastoris expression platform is based on its proprietary AOX1 promoter libraries and set of expression enhancing helper factors, several platform strains with different genetic backgrounds, elaborated cloning and transformation protocols, a high-throughput screening and cultivation regime combined with excellent know-how in fermentation and downstream process development for maximization of product yield and overall process performance.

Headquartered in Grambach, near Graz, Austria, VTU Technology is a private company and a subsidiary of VTU Holding, an Austrian enterprise that combines several technology and engineering companies in chemistry, pharma and life science as well as in the energy industries. More information at:,

About BIO-International 2016

The BIO-International® Convention is a flagship conference providing life science companies with further high caliber knowledge sharing and partnering opportunities. The convention attracts some 2,500 CEOs from the pharmaceutical and biotech industries.

The BIO-International convention has been running since 2003 and consistently attracts executives from established and emerging pharma and biotech companies, along with academic researchers and private investors including venture capital and private equity and organizations developing companion diagnostics.

The 2016 BIO-International Convention is a four-day event opening June 6 at the Moscone Center in downtown San Francisco. The Convention will play host to almost 4,000 exhibitors and is expected to increase visitor numbers for the tenth year in succession. More than 15,500 people, from 66 countries, attended the 2015 convention in Philadelphia.

The sophisticated One-on-One™ web-based partnering system was used to facilitate more than 29,000 meetings, involving more than 3,000 companies.

The US Biotechnology Industry Organization organizes the Convention, with more information at:


Simply fill out the form below to contact VALIDOGEN GmbH now.

Send VALIDOGEN GmbH a Message